Improving Communication With GPs Post-STEMI

JJ Coughlan; Conor Hickie; Barbara Gorna; Ross Murphy; Peter Crean

Disclosures

Br J Cardiol. 2016;23(4):138-140. 

In This Article

Results

Our results are summarised in Table 1 and Table 2.

Our initial study highlighted that there was significant room for improvement in communication with GPs. Only 19.87% of our discharge summaries informed the GP to up-titrate BB and ACEi to the maximally tolerated dose, however, therapeutic prescribing rates for these medications were only 17.4% and 14.14%, respectively. While some patients may have had contraindications to higher doses of these medications (bradycardia, hypotension, renal disease), it was felt to be unlikely that this was the case in over 80% of our patients.

Just over half of our discharge summaries informed the GP of the duration of antiplatelet therapy and only 36.8% informed them to repeat fasting lipids. This was despite only two-thirds of our patients being prescribed a therapeutic dose of a statin.

After our intervention, we achieved a statistically significant improvement in rates of communication with GPs with regard to duration of antiplatelet therapy and up-titration of medications. There was no statistically significant difference in communication regarding repeat testing of fasting lipid profiles (p=0.1936).

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....